TY - JOUR
T1 - Quantitative analysis of cytokine mRNA expression in peripheral blood mononuclear cells following treatment with interleukin-2
AU - Adachi, Masashi
AU - Inoue, Hiroshi
AU - Arinaga, Shinya
AU - Li, Jian
AU - Ueo, Hiroaki
AU - Mori, Masaki
AU - Akiyoshi, Tsuyoshi
PY - 1997
Y1 - 1997
N2 - After activation with interleukin-2 (IL-2), peripheral blood mononuclear cells (PBMC) have been reported to induce the expression of mRNA coding various cytokines, including interleukin(IL)-1α, -1β and tumor necrosis factor α (TNFα). We examined the cytokine mRNA expression of PBMC following treatment with IL-2 in vitro and in vivo by a quantitative method using the reverse transcription/polymerase chain reaction (RTPCR). After stimulating PBMC with IL-2 in vitro, peak levels of IL-1α mRNA were reached between 3 h and 12 h, and thereafter declined. The IL-1β expression increased, with levels peaking at 1-6 h and, had decreased by 96 h. The expression of TNFα was elevated both 1-3 h and 2448 h after stimulation. The peak levels of IL- 1α and -1β mRNA and the early elevation of TNFα mRNA mainly accounted for the cytokine mRNA expression in adherent cells; however, the late induction of TNFα mRNA was observed in nonadherent cells. In patients with advanced carcinoma, the IL-1α and -1β mRNA expression were elevated after IL-2 treatment for 5 consecutive days, while the expression of TNFα mRNA also increased. These results indicate that the quantitative RT-PCR method appears to be useful for analyzing the cytokine mRNA expression of PBMC after treatment with IL-2.
AB - After activation with interleukin-2 (IL-2), peripheral blood mononuclear cells (PBMC) have been reported to induce the expression of mRNA coding various cytokines, including interleukin(IL)-1α, -1β and tumor necrosis factor α (TNFα). We examined the cytokine mRNA expression of PBMC following treatment with IL-2 in vitro and in vivo by a quantitative method using the reverse transcription/polymerase chain reaction (RTPCR). After stimulating PBMC with IL-2 in vitro, peak levels of IL-1α mRNA were reached between 3 h and 12 h, and thereafter declined. The IL-1β expression increased, with levels peaking at 1-6 h and, had decreased by 96 h. The expression of TNFα was elevated both 1-3 h and 2448 h after stimulation. The peak levels of IL- 1α and -1β mRNA and the early elevation of TNFα mRNA mainly accounted for the cytokine mRNA expression in adherent cells; however, the late induction of TNFα mRNA was observed in nonadherent cells. In patients with advanced carcinoma, the IL-1α and -1β mRNA expression were elevated after IL-2 treatment for 5 consecutive days, while the expression of TNFα mRNA also increased. These results indicate that the quantitative RT-PCR method appears to be useful for analyzing the cytokine mRNA expression of PBMC after treatment with IL-2.
UR - http://www.scopus.com/inward/record.url?scp=0030758667&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030758667&partnerID=8YFLogxK
U2 - 10.1007/s002620050390
DO - 10.1007/s002620050390
M3 - Article
C2 - 9298935
AN - SCOPUS:0030758667
SN - 0340-7004
VL - 44
SP - 329
EP - 334
JO - Cancer Immunology Immunotherapy
JF - Cancer Immunology Immunotherapy
IS - 6
ER -